Wrapping Up the Discussion on the Use of Catheters for Fistula Prevention and Treatment: Dr. Ruminjo Replies

first_imgPosted on June 21, 2010July 14, 2014Click to share on Facebook (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window)Over the past couple weeks, Dr. Fatouma Mabeye, the Medical Coordinator for WAHA International, and Dr. Joseph Ruminjo, the Clinical Director for the Fistula Care Project, have engaged in a lively public dialogue (via the MHTF Blog) around the use of catheters for prevention and treatment of fistula. Take a look at the previous posts in this series: Dr. Mabeye’s first post, Dr. Ruminjo’s reply, and Dr. Mabeye’s reply.Dr. Ruminjo’s closing remarks:Thank you for the detailed and insightful comments.This is certainly a very useful and evolving approach, so a continuing discussion of the evidence base as it is gradually built up is rewarding, even when not all the answers are immediately available at research and programmatic level.Just a clarificication, in case this was not apparent: EngenderHealth/Fistula Care Project does indeed recognize, and support implementation of bladder catheterisation as one of the key interventions both for prevention of fistula after obstructed labor and for treatment of select cases of fistula.Special thanks to Dr. Mabeye and Dr. Ruminjo. Our readers have enjoyed ‘tuning in’ to a very informative conversation about the use of catheters to prevent and treat fistula. Readers, please let us know other topics that you would like to see covered on the MHTF Blog. Submit your ideas in the comments section of this post!Share this: ShareEmailPrint To learn more, read:last_img